Pulmonary Epidemiology

Program Description

TThe Pulmonary Epidemiology Program at Penn includes funded research in several major diverse areas of pulmonary diseases, including lung transplantation, Acute Lung Injury (ALI) and Acute Respiratory Distress syndrome (ARDS), critical illness, asthma, Chronic Obstructive Pulmonary Disease (COPD), pulmonary imaging, interstitial lung diseases, sleep disorders, pulmonary hypertension, and lung cancer. Methodological areas include genetic epidemiology, proteomics, genomics, medication adherence, long term outcomes of critical illness, imaging, gene transfer, clinical trials of novel therapeutics, and cancer screening. Ongoing epidemiological studies include large numbers of well characterized subjects in airways diseases, ALI/ARDS, lung transplantation, lung cancer, mesothelioma, and idiopathic pneumonias.

The research efforts of the group are supported by numerous large federal and non-federal grants, including an NHLBI program project focusing on ALI/ARDS etiology and pathogenesis, the NIH Clinical Trials in Organ Transplantation Consortium, a SCOR grant in asthma research, a large Pennsylvania Department of Health grant focusing on proteomics and lung cancer screening, an RO1 focusing on genetics of Idiopathic Interstitial pneumonias, a large foundation grant creating the Registry for Airways disease research, an RO1 focusing on asthma medication adherence, an NIH program project focusing on immunotherapy of mesothelioma and lung cancer, and several RO1 grants focusing on pulmonary imaging. Investigators participating in pulmonary epidemiology programs are listed below.

Program Members

Penn Medicine CCEB Home